|
Name |
Octyl formate
|
Molecular Formula | C9H18O2 | |
IUPAC Name* |
octyl formate
|
|
SMILES |
CCCCCCCCOC=O
|
|
InChI |
InChI=1S/C9H18O2/c1-2-3-4-5-6-7-8-11-9-10/h9H,2-8H2,1H3
|
|
InChIKey |
AVBRYQRTMPHARE-UHFFFAOYSA-N
|
|
Synonyms |
Octyl formate; 112-32-3; n-Octyl formate; FORMIC ACID, OCTYL ESTER; Octyl methanoate; n-Octyl methanoate; Octyl alcohol, formate; formic acid octyl ester; 1-Octyl formate; FEMA No. 2809; Octyl formiate; 2XZ47CUU7G; NSC-404473; EINECS 203-959-5; UNII-2XZ47CUU7G; NSC 404473; BRN 1755259; octylformate; Octyl alcohol, formate (6CI); Formic acid octyl; N- octyl formate; 1- octyl formate; Formic acid, octylester; OCTYL FORMATE [FCC]; SCHEMBL79532; N-OCTYL FORMATE [FHFI]; DTXSID4059417; Octyl formate, >=97%, FCC; CHEBI:87496; FEMA 2809; ZINC1597281; LMFA07010980; MFCD00046147; NSC404473; AKOS024437507; DB-041076; FT-0631644; E79227; Q3077502
|
|
CAS | 112-32-3 | |
PubChem CID | 8176 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 158.24 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.4 |
Caco-2 Permeability: | -4.5 | MDCK Permeability: | 0.00003230 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.148 |
30% Bioavailability (F30%): | 0.951 |
Blood-Brain-Barrier Penetration (BBB): | 0.998 | Plasma Protein Binding (PPB): | 58.23% |
Volume Distribution (VD): | 1.126 | Fu: | 36.67% |
CYP1A2-inhibitor: | 0.979 | CYP1A2-substrate: | 0.344 |
CYP2C19-inhibitor: | 0.708 | CYP2C19-substrate: | 0.259 |
CYP2C9-inhibitor: | 0.399 | CYP2C9-substrate: | 0.736 |
CYP2D6-inhibitor: | 0.096 | CYP2D6-substrate: | 0.153 |
CYP3A4-inhibitor: | 0.081 | CYP3A4-substrate: | 0.126 |
Clearance (CL): | 5.142 | Half-life (T1/2): | 0.594 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.108 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.022 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.922 | Carcinogencity: | 0.578 |
Eye Corrosion: | 0.939 | Eye Irritation: | 0.972 |
Respiratory Toxicity: | 0.307 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000606 | 0.639 | D05ATI | 0.444 | ||||
ENC002416 | 0.595 | D01QLH | 0.395 | ||||
ENC000267 | 0.590 | D0Z5SM | 0.393 | ||||
ENC000049 | 0.556 | D0AY9Q | 0.377 | ||||
ENC000897 | 0.556 | D0Z5BC | 0.340 | ||||
ENC000261 | 0.556 | D0E4WR | 0.320 | ||||
ENC000032 | 0.556 | D0Y8DP | 0.309 | ||||
ENC000460 | 0.553 | D03ZJE | 0.304 | ||||
ENC001601 | 0.548 | D0XN8C | 0.304 | ||||
ENC000275 | 0.548 | D07ILQ | 0.300 |